Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review

ObjectiveTo elucidate the clinicopathological features and treatment of metastatic gastroesophageal junction hepatoid adenocarcinoma (GEJ HAC)using a case study and literature review.MethodsClinical presentation, results of histology and immunohistochemistry, and next-generation sequencing(NGS) in a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Genlin Lu, Jiarui Tu, Jinming Tu, Renya Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	gastroesophageal junction hepatoid adenocarcinoma chemotherapy sintilimab liver metastasis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1513604/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary pancreatic hepatoid carcinoma: A case report
by: Shizheng Mi, et al.
Published: (2025-02-01)

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy
by: Huanhuan Li, et al.
Published: (2025-02-01)

Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report
by: Xiaoli Wang, et al.
Published: (2025-02-01)

Kyoto International Consensus Report on Anatomy, Pathophysiology and Clinical Significance of the Gastroesophageal Junction
by: A. A. Sheptulin, et al.
Published: (2023-12-01)

Primary Pancreatic Hepatoid Carcinoma: A Case Report and Literature Review
by: Tyng-Wei Yang, et al.
Published: (2023-07-01)

Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010-12-01)

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
by: Ming-xing Wang, et al.
Published: (2025-01-01)

The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma
by: Ruifeng Wang, et al.
Published: (2025-01-01)

A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews
by: France Ginchereau Sowell, et al.
Published: (2025-01-01)

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1
by: Pei Zhu, et al.
Published: (2025-02-01)

Comparative efficacy of programmed death ligand 1 inhibition and chemotherapy in advanced gastric or gastroesophageal junction cancer with combined positive score – a meta-analysis
by: Zakari Shaibu, et al.
Published: (2024-10-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
by: Chengyang Yu, et al.
Published: (2025-01-01)

A novel scoring system proposal to guide treatment of dogs with hepatoid gland tumors
by: Lorella Maniscalco, et al.
Published: (2025-02-01)

The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma
by: O. A. Storonova, et al.
Published: (2024-08-01)

Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trialResearch in context
by: Xiangyang Yu, et al.
Published: (2025-01-01)

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
by: Yingyi Li, et al.
Published: (2025-02-01)

Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
by: Yan Zhang, et al.
Published: (2025-12-01)

Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
by: Xiaoyang Hong, et al.
Published: (2025-02-01)

Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study
by: Tongji Xie, et al.
Published: (2024-12-01)

Modern potentials of prokinetics in treatment of gastroesophageal reflux disease
by: A. A. Sheptulin, et al.
Published: (2010-11-01)

Gastroesophageal reflux disease at children: epidemiology, diagnostic criteria, prognosis
by: E. M. Mukhametova, et al.
Published: (2010-02-01)

Evaluating survival outcomes and treatment recommendations in resectable gastric cancer
by: Saad Sabbagh, et al.
Published: (2025-01-01)

Modern options and prospects of treatment of resistant forms of gastroesophageal reflux disease
by: A. A. Sheptulin
Published: (2010-12-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

Mucin-producing urothelial-type adenocarcinoma of the prostate with a gene mutation characteristic of intestinal adenocarcinoma: case report and literature review
by: Ao Yu, et al.
Published: (2025-01-01)

Systemic immune response at gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-10-01)

Disorders of esophageal clearance in gastroesophageal reflux disease and option of their treatment
by: O. A. Storonova, et al.
Published: (2012-04-01)

Relationship between Helicobacter pylori infection and gastroesophageal reflux disease
by: Seda Yılmaz, et al.
Published: (2024-12-01)

A mathematical model of the Purkinje-Muscle Junctions
by: Adnane Azzouzi, et al.
Published: (2011-07-01)

Comparison of the safety of esophagojejunal overlap and π-shaped anastomosis in totally laparoscopic total gastrectomy
by: Tongkun Song, et al.
Published: (2025-01-01)

Primary Adenocarcinoma of the Vermiform Appendix. A Case Report
by: Luis Antonio Revuelta Pérez, et al.
Published: (2014-11-01)

Mucinous rectal adenocarcinoma recurrence: A case report and literature review
by: Riya Sood, BS, et al.
Published: (2025-04-01)

Results of multicenter observation study on application of international questionnaire GerdQ for diagnostics of gastroesophageal reflux disease
by: V. O. Kaybysheva, et al.
Published: (2013-10-01)

The refractory form of gastroesophageal reflux disease: clinical and endoscopical, functional and morphofunctional criteria
by: M. A. Osadchuk, et al.
Published: (2011-03-01)

Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)

Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
by: Run-Cong Nie, et al.
Published: (2025-02-01)

Tight junction proteins in glial tumors development and progression
by: Jakub Moskal, et al.
Published: (2025-02-01)

Adherent junctions: Physiology, role in hydrocephalus and potential therapeutic targets
by: Zhiye Chen, et al.
Published: (2025-06-01)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
by: Yuan Tian, et al.
Published: (2021-01-01)